Overview

A Study To Examine Safety, Pharmacokinetics, And Pharmacodynamic Of Pf 06412562 In Healthy Males

Status:
Terminated
Trial end date:
2016-06-14
Target enrollment:
Participant gender:
Summary
This study is designed to investigate the safety, tolerability pharmacokinetics and pharmacodynamic effects of PF-06412562 following multiple dose administration as MR tablets in healthy adult males.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer